MedTrace Logo

Vitamin D Supplementation and CD4 Count in HIV-Infected Children

NCT00911664 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2014-06-06

No results posted yet for this study

Summary

To find out if vitamin D supplementing can lead to an improvement in immunological status in HIV-infected children as part of routine clinical care

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D

Weekly dose of 5600 IU (800 IU per day)

DRUG

No supplementation

Control

DIETARY_SUPPLEMENT

Vitamin D

Weekly dose of 11,200 IU (1600 IU per day)

Sponsors & Collaborators

  • The Hospital for Sick Children

    lead OTHER

Principal Investigators

  • Ari Bitnun, MD · The Hospital for Sick Children

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2009-10-31
Completion
2010-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00911664 on ClinicalTrials.gov